Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jul;27(7):3882-3890.
doi: 10.1111/dom.16417. Epub 2025 May 13.

The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case-control study

Riemer A Been  1 , Max R X van Helsdingen  1 , Darren Zammit  2 , Marco Grzegorczyk  3 , Wim P Krijnen  3 , Katalin Tamasi  4   5 , Rijk O B Gans  6 , André P van Beek  1 , Peter R van Dijk  1   7
Affiliations
Observational Study

The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case-control study

Riemer A Been et al. Diabetes Obes Metab. 2025 Jul.

Abstract

Aims: The efficacy of intermittently scanning continuous glucose monitoring (is-CGM) technology among elderly people with diabetes mellitus (DM) has been understudied. We investigated if the initiation of is-CGM results in improved glycemic control among this population.

Materials and methods: Retrospective, observational case-control study. Cases were selected randomly from the DM outpatient clinic of the University Medical Center Groningen between 2015 and 2022 if they had type 1 or type 2 DM, were registered users of is-CGM devices and were aged 60 or older at initiation of those devices. They were matched to randomly selected controls with no CGM usage based on age, gender, DM type and treatment type (insulin-pen or pump). Data were collected at baseline, 6 months prior and 3, 6, 9, 12 and 24 months after initiation. Linear mixed-effects regression was performed to assess the effects of is-CGM usage on HbA1c.

Results: Three hundred and fifty-three participants were analysed (142 cases, 211 controls). Median HbA1c at baseline for is-CGM users was 8.00% [7.20%-9.10%] and for controls 7.90% [7.10%-8.70%]. Unadjusted analysis showed significant reductions of HbA1c 3 months after initialization (cases vs. controls, -0.50% vs. -0.02%, p = 0.016), persisting throughout the study. Adjusting for confounders, is-CGM initiation resulted in significant HbA1c reductions after 6 months (-0.29%, p = 0.006) up until 24 months (-0.39%, p = 0.033). The rate of sensor discontinuation was 2.8%.

Conclusions: The use of is-CGM improves glycemic control in elderly (≥60 years old) persons with DM after 3 months, and this persists for at least 24 months. The number of discontinuations is low. This data emphasizes the positive impact of is-CGM on the elderly population with DM.

Keywords: blood glucose self‐monitoring; diabetes mellitus; elderly; insulin therapy; intermittently scanned continuous glucose monitoring.

PubMed Disclaimer

Conflict of interest statement

Peter R. van Dijk is funded by an unrestricted educational grant from the European Foundation for the Study of Diabetes (EFSD) mentorship programme supported by AstraZeneca. The remaining authors declare no conflicts of interest.

References

    1. Krakauer M, Botero JF, Lavalle‐González FJ, Proietti A, Barbieri DE. A review of flash glucose monitoring in type 2 diabetes. Diabetol Metab Syndr. 2021;13(1):42. doi:10.1186/S13098-021-00654-3 - DOI - PMC - PubMed
    1. Addala A, Auzanneau M, Miller K, et al. A decade of disparities in diabetes technology use and HbA 1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care. 2021;44(1):133‐140. doi:10.2337/DC20-0257 - DOI - PMC - PubMed
    1. Munshi MN, Meneilly GS, Rodríguez‐Mañas L, et al. Diabetes in ageing: pathways for developing the evidence base for clinical guidance. Lancet Diabetes Endocrinol. 2020;8(10):855‐867. doi:10.1016/S2213-8587(20)30230-8 - DOI - PMC - PubMed
    1. Toschi E, Munshi MN. Benefits and challenges of diabetes technology use in older adults. Endocrinol Metab Clin North Am. 2020;49(1):57‐67. doi:10.1016/J.ECL.2019.10.001 - DOI - PMC - PubMed
    1. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in Older Adults. Diabetes Care. 2012;35(12):2650‐2664. doi:10.2337/DC12-1801 - DOI - PMC - PubMed

Publication types

MeSH terms